Andrew T Stefka

6PUBLICATIONS
37CO-AUTHORS
Intelligent roboticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 14, 2024
Performance of an AI-powered visualization software platform for precision surgery in breast cancer patients.

Michelle Weitz, J R Pfeiffer, Snehal Patel

|Sep 10, 2023
Polyclonal immunoglobulin recovery in patients with newly diagnosed myeloma receiving maintenance therapy after autologous haematopoietic stem cell transplantation with either carfilzomib, lenalidomide and dexamethasone or lenalidomide alone: Subanalysis of the randomized phase 3 ATLAS trial.

Tadeusz Kubicki, Dominik Dytfeld, Tomasz Wróbel

|Feb 10, 2023
Phase 1/2 study of carfilzomib, pomalidomide, and dexamethasone with and without daratumumab in relapsed multiple myeloma.

Benjamin A Derman, Jeffrey Zonder, Donna Reece

|Feb 02, 2023
A phase I study of selinexor combined with weekly carfilzomib and dexamethasone in relapsed/refractory multiple myeloma.

Benjamin A Derman, Ajai Chari, Jeffrey Zonder

|Feb 10, 2021
Measurable residual disease assessed by mass spectrometry in peripheral blood in multiple myeloma in a phase II trial of carfilzomib, lenalidomide, dexamethasone and autologous stem cell transplantation.

Benjamin A Derman, Andrew T Stefka, Ken Jiang

|Nov 13, 2019
Potent anti-myeloma activity of the TOPK inhibitor OTS514 in pre-clinical models.

Andrew T Stefka, David Johnson, Shaun Rosebeck

Pageof 1

Frequent Collaborators

4 joint publications

Benjamin A Derman

3 joint publications

Andrzej Jakubowiak

2 joint publications

Tadeusz Kubicki

1 joint publications

Dominik Dytfeld